PTX3 and COVID-19: Pentraxin‐3 (PTX3), which is associated with proinflammation and endothelial injury similar to classical pentraxin (CRP), was also significantly upregulated in SEVs in all symptomatic COVID‐19 patients with levels increasing with severity of illness.